These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 4216916

  • 21. [Causes of failure in neutralization, recovery and social rehabilitation of chronic eliminators of Koch bacilli treated with rifampin and ethambutol].
    Barbu Z, Alexa M, Josefovics F.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(3):153-9. PubMed ID: 212812
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C, Andreis G.
    G Ital Chemioter; 1966; 13(1):109-27. PubMed ID: 4967318
    [No Abstract] [Full Text] [Related]

  • 23. [Ethambutol and pulmonary tuberculosis].
    Pilheu JA, Iannello JA, Palermo F.
    Torax; 1969 Jun; 18(2):91-6. PubMed ID: 4982009
    [No Abstract] [Full Text] [Related]

  • 24. [Liver function in patients with chronic destructive pulmonary tuberculosis during complex treatment with rifampicin and ethambutol].
    Kharakter ZhZ, Chertkova MA, Pavlenko AV.
    Probl Tuberk; 1975 Jun; (10):44-8. PubMed ID: 1208440
    [No Abstract] [Full Text] [Related]

  • 25. [Test of short-term monotherapy in the clinical evaluation of the action of antitubercular agents].
    Anastasatu C, Bercea O, Marcian S, Ceicu A.
    Arch Monaldi; 1971 Jun; 26(4):291-9. PubMed ID: 5004576
    [No Abstract] [Full Text] [Related]

  • 26. [Bacteriological relapse among the previously treated advanced pulmonary tuberculosis patients whose sputum converted to negative by the rifampicin treatment, with special reference to the duration of rifampicin administration (author's transl)].
    Yamamoto M, Morishita M, Hirano Y, Nagata A, Yazaki M.
    Kekkaku; 1974 Jul; 49(7):195-9. PubMed ID: 4214961
    [No Abstract] [Full Text] [Related]

  • 27. [Ethambutol in the chemotherapy of patients with fibrocavernous tuberculosis of the lungs].
    Utkin VV, Poleshchuk AK, Zankisova IG, Mkrtchian SV, Krylova NP, Gridneva SM.
    Probl Tuberk; 1971 Jul; 49(7):27-32. PubMed ID: 5005808
    [No Abstract] [Full Text] [Related]

  • 28. [Results of 6-month and 9-month treatments with rifampin, isoniazid and ethambutol in cases of newly detected tuberculosis].
    Szymanski A, Gaik A.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981 Jul; 30(3):181-3. PubMed ID: 6273991
    [No Abstract] [Full Text] [Related]

  • 29. [Sputum positive conversion among retreatment cases with pulmonary tuberculosis converted to negative by the use of rifampicin (author's transl)].
    Ito F, Okochi T, Yamazaki M, Yamamoto Y, Kondo K, Konishiike J, Asahi T.
    Kekkaku; 1979 Jan; 54(1):37-42. PubMed ID: 107360
    [No Abstract] [Full Text] [Related]

  • 30. [Bacteriologic results and relapses of sputum-positive reactions in 110 tuberculous patients treated with ethambutol].
    Szarewicz-Adamczyk W, Przemyska B, Mysakowska H, Grodzki S, Marciniak T.
    Gruzlica; 1974 Mar; 42(3):221-7. PubMed ID: 4822090
    [No Abstract] [Full Text] [Related]

  • 31. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV, Pashkov IuN, Pospelov VV.
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract] [Full Text] [Related]

  • 32. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
    Dhingra VK, Rajpal S, Bhalla P, Yadav A, Jain SK, Hanif M.
    J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
    [Abstract] [Full Text] [Related]

  • 33. [Results of follow-up on advanced cases of pulmonary tuberculosis converted to negative with rifampicin treatment].
    Yamamoto M, Isoe K, Nakamura H, Hirose H, Izumi S.
    Kekkaku; 1972 Nov; 47(11):393-7. PubMed ID: 4630902
    [No Abstract] [Full Text] [Related]

  • 34. [Ethambutol in chemotherapy of patients with fibro-cavitary tuberculosis of the lungs].
    Utkin VV, Poleshchuk AK, Zankisova IG, Mkrtchian SV, Krylova NP.
    Probl Tuberk; 1971 Nov; 49(7):27-32. PubMed ID: 5004349
    [No Abstract] [Full Text] [Related]

  • 35. [Comparative data from an experimental-clinical study of new antituberculosis drugs].
    Utkin VV.
    Antibiotiki; 1972 Sep; 17(9):851-6. PubMed ID: 4631726
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.